HUMA Company Profile and Key Details

Q: Who are the executives of HUMA?

Dr. Yang Cao M.D., Ph.D.Chief Regulatory OfficerMr. Harold AltersonSenior Vice President of QualityDr. Shamik J. Parikh M.D.Chief Medical OfficerMs. Sabrina OsborneExecutive Vice President of Bus. Strategy & PeopleDr. Heather Ledbetter Prichard Ph.D.Chief Operating OfficerMr. Dale A. SanderChief Financial Officer, Chief Corporation Devel. Officer & TreasurerMr. William John ScheesseleChief Commercial OfficerDr. Juliana L. Blum Ph.D.Co-Founder & Executive AdvisorDr. Laura E. Niklason M.D., Ph.D.Founder, Pres, Chief Executive Officer & Director

NASDAQ : HUMA

Humacyte

$0.84

0.0218+2.66%

At Close 4:00 PM

78.77

A-ESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Humacyte, Inc. (HUMA) stock surged +1.60%, trading at $0.86 on NASDAQ, up from the previous close of $0.84. The stock opened at $0.83, fluctuating between $0.82 and $0.86 in the recent session.

Stock Snapshot

0.8418

Prev. Close

134.08M

Market Cap

0.8165

Day Low

-3.29

P/E Ratio

-0.26

EPS (TTM)

-0.73

Cash Flow per Share

0.83

Open

156.77M

Number of Shares

0.8591

Day High

79%

Free Float in %

0.13

Book Value

2.03M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Apr 30, 2026	0.82	0.85	0.80	0.84	2.89M
Apr 29, 2026	0.82	0.84	0.80	0.82	3.46M
Apr 28, 2026	0.83	0.85	0.76	0.85	5.22M
Apr 27, 2026	0.71	0.83	0.70	0.81	7.94M
Apr 23, 2026	0.71	0.76	0.68	0.71	4.48M
Apr 22, 2026	0.68	0.72	0.67	0.70	4.61M
Apr 21, 2026	0.69	0.71	0.65	0.66	4.12M
Apr 20, 2026	0.70	0.72	0.68	0.69	3.91M
Apr 17, 2026	0.72	0.75	0.70	0.71	5.04M
Apr 16, 2026	0.75	0.76	0.68	0.68	5.27M
Apr 14, 2026	0.67	0.73	0.67	0.69	4.09M
Apr 13, 2026	0.64	0.70	0.64	0.67	4.65M
Apr 10, 2026	0.61	0.67	0.60	0.65	4.64M
Apr 09, 2026	0.65	0.67	0.61	0.61	4.59M
Apr 08, 2026	0.65	0.67	0.62	0.65	4.64M
Apr 07, 2026	0.63	0.64	0.60	0.61	4.79M
Apr 06, 2026	0.66	0.71	0.65	0.65	5.2M
Apr 02, 2026	0.58	0.66	0.58	0.64	4.71M
Apr 01, 2026	0.63	0.63	0.57	0.59	6.1M
Mar 31, 2026	0.59	0.63	0.56	0.61	7.06M

Contact Details

Durham, NC 27713

United States

https://www.humacyte.com 919 313 9633

About Company

Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular vessels (HAVs). Its investigational HAVs are designed to be easily implanted into any patient without inducing a foreign body response or leading to immune rejection. The company is developing a portfolio of HAVs, which would target the vascular repair, reconstruction, and replacement market, including vascular trauma; arteriovenous access for hemodialysis; peripheral arterial disease; and coronary artery bypass grafting, as well as developing its HAVs for pediatric heart surgery and cellular therapy delivery, including pancreatic islet cell transplantation to treat Type 1 diabetes. The company was founded in 2004 and is headquartered in Durham, North Carolina.

Stock Peers

ARGX

5.7+0.73%

argenx SE$781.72 REGN

20.7+3.02%

Regeneron Pharmaceuticals, Inc.$707.06 UTHR

0.28+0.05%

United Therapeutics Corporation$571.35 MDGL

-1.19-0.23%

Madrigal Pharmaceuticals, Inc.$517.39 VRTX

4.14+0.98%

Vertex Pharmaceuticals Incorporated$427.38 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 PRAX

-4.36-1.35%

Praxis Precision Medicines, Inc.$318.83 ALNY

8.3+2.76%

Alnylam Pharmaceuticals, Inc.$309.49 KRYS

2.31+0.89%

Krystal Biotech, Inc.$262.26 LGND

4.59+2.04%

Ligand Pharmaceuticals Incorporated$229.45

Frequently Asked Questions

What is the current Humacyte, Inc. (HUMA) stock price?

Humacyte, Inc. (NASDAQ: HUMA) stock price is $0.86 in the last trading session. During the trading session, HUMA stock reached the peak price of $0.86 while $0.82 was the lowest point it dropped to. The percentage change in HUMA stock occurred in the recent session was 1.6% while the dollar amount for the price change in HUMA stock was $0.01.

HUMA's industry and sector of operation?

The NASDAQ listed HUMA is part of Biotechnology industry that operates in the broader Healthcare sector. Humacyte, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of HUMA?

Dr. Yang Cao M.D., Ph.D.
Chief Regulatory Officer
Mr. Harold Alterson
Senior Vice President of Quality
Dr. Shamik J. Parikh M.D.
Chief Medical Officer
Ms. Sabrina Osborne
Executive Vice President of Bus. Strategy & People
Dr. Heather Ledbetter Prichard Ph.D.
Chief Operating Officer
Mr. Dale A. Sander
Chief Financial Officer, Chief Corporation Devel. Officer & Treasurer
Mr. William John Scheessele
Chief Commercial Officer
Dr. Juliana L. Blum Ph.D.
Co-Founder & Executive Advisor
Dr. Laura E. Niklason M.D., Ph.D.
Founder, Pres, Chief Executive Officer & Director

How HUMA did perform over past 52-week?

HUMA's closing price is 53.89% higher than its 52-week low of $0.55 where as its distance from 52-week high of $2.93 is -71.27%.

How many employees does HUMA have?

Number of HUMA employees currently stands at 218.

Link for HUMA official website?

Official Website of HUMA is: https://www.humacyte.com

How do I contact HUMA?

HUMA could be contacted at phone 919 313 9633 and can also be accessed through its website. HUMA operates from 2525 East North Carolina Highway 54, Durham, NC 27713, United States.

How many shares of HUMA are traded daily?

HUMA stock volume for the day was 2.03M shares. The average number of HUMA shares traded daily for last 3 months was 6.94M.

What is the market cap of HUMA currently?

The market value of HUMA currently stands at $134.08M with its latest stock price at $0.86 and 156.77M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	218
Beta	2.1
Sales or Revenue	$0.00
5Y Sales Change%	-1%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	218
Beta	2.1
Sales or Revenue	$0.00
5Y Sales Change%	-1%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

HUMA Company Profile and Key Details

Humacyte

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Financial & Profitability Overview

Quarterly Financial Highlights

Technical Performance

Shareholding & Insider Activity

Dividend & Fair Value

Earnings & Analyst Outlook

Company Overview

Key Takeaways

Price Forecast & Outlook

Valuation Metrics